Oxford Gene Technology (OGT) will be hosting booths at two key US cytogenetics meetings over the next few weeks.
The first is the Association for Molecular Pathology (AMP) Annual Meeting on Genomic Medicine 2012 to be held in Long Beach, CA (25-27 October), and the second the American Society of Human Genetics Annual Meeting 2012 in San Francisco, CA (6-10 November).
Pathologists and cytogeneticists can visit the OGT booths to discuss the challenges currently facing molecular pathology with the company’s experts.
Perhaps most excitingly, OGT will be making a major announcement at the ASHG meeting, full details of which will be made publicly available after the meeting.
OGT has significant expertise in the area of cytogenetic analysis and has recently released a new series of microarrays specifically enhanced for investigating the genetic basis of cancer and other congenital diseases, including the CytoSure™ Haematological Cancer +SNP Array and the CytoSure ISCA +SNP Array, with enhanced SNP resolution.
By combining both aCGH and SNP probes, these arrays make it is possible to carry out the accurate and cost-effective detection of both copy number changes and loss of heterozygosity, all in a single experiment.
Analysis is further optimized via seamless integration with OGT’s powerful CytoSure Interpret Software, which rapidly and intuitively guides researchers to the important genetic variations in their samples, without the need for extensive bioinformatics expertise.